Clinical Trial Update: of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining the effects of SGLT2 inhibitors on metabolic, hormonal, and clinical parameters in polycystic ovary syndrome (PCO).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Beni-Suef University | Conditions: PCO | Phase 3 | Status: UNKNOWN